Potassium iodate/iodide 2021-22
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 26 Apr 2021 |
| Contract start | 1 Jul 2021 |
| Contract end | 31 Mar 2022 |
| Procedure | selective |
| SME suitable | Yes |
| OCID | ocds-b5fd17-2ab23acc-8dfe-497f-ba91-acc5fae91683 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Hameln pharma ltd | £1 | 7 Jun 2021 | active |
description
A specific procurement under a dynamic purchasing system ref CM/EMP/21/21025 for the supply of antidotes and antibiotics, for the provision of potassium iodate_iodide tablets 2021-22.
The contract value is withheld from publication as the authority has deemed that its release would be contrary to the public interest.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 1 Jul 2021 | Award (award) | · | 2153da48-1897-4e55-9a2b-4ce6771c2f5e-447869 |
more from Secretary of State for Health and Social Care acting as part of the Crown through Public Health England
- National Drug Treatment Management Service – Analytics · 4 Nov 2021
- PHE Service Floors Steam Works · 14 Oct 2021
- PHE_ICT_Genomic Laboratory Non-Invasive Prenatal Testing Service (NIPT) · 7 Oct 2021
- Genomic Laboratory Non-Invasive Prenatal Testing Service (NIPT) · 7 Oct 2021
- PHE - Specialist Software and Control System Framework · £15,000,000 · 5 Oct 2021
- PHE Autoclaves Framework · £1,000,000 · 21 Sept 2021
- PHE - Corporate - Prevalence Estimates of Harmful Gambling Treatment and Support · £150,000 · 25 Aug 2021
- Cabinet Line · £3,000,000 · 22 Jun 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.